Suchergebnisse - "Salazar, Ramon"

PubPharm (12)

1

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER) : a multicentre, open-label, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von Strickler, J. | Cercek, A. | Siena, S. | +84

2

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma : long term results

enthalten in: BMC cancer | 2020

von Salazar, R. | Capdevila, J. | Manzano, J. | +15

3

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors : The GETNE1003_EVERLAR Study

enthalten in: The oncologist | 2019

von Capdevila, J. | Teulé, A. | Barriuso, J. | +11

4

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors

enthalten in: The oncologist | 2018

von Salazar, R. | Garcia-Carbonero, R. | Libutti, S. | +16

5

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

6

Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial)

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Petty, R. | Anthoney, A. | Metges, J. | +10

7

Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

enthalten in: BMC cancer | 2015

von García, M. | Martinez-Villacampa, M. | Santos, C. | +13

8

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer : clinical and biological features

enthalten in: BMC cancer | 2015

von Salazar, R. | Capdevila, J. | Laquente, B. | +15

9

Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies : a nonrandomized, open-label, phase II trial

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Becerra, C. | Salazar, R. | Garcia-Carbonero, R. | +9

10

Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour : a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2013

von Castellano, D. | Capdevila, J. | Sastre, J. | +7